Search
SOLACI Congress
HomeFileCoronary disease

Coronary disease

View Category

Coronary disease

Abluminal Sirolimus and luminal CD34 antibody layer: Is COMBO the Future of Stents?

This large cohort of patients treated with the dual therapy COMBO stent has showed excellent outcomes after...
solaci -
Learn More
Chronic Ischemic cardiopathy

Revascularization in Patients with Multivessel Disease, Diabetes, and Kidney Disease

According to this new study, in patients with coronary disease, diabetes, and chronic kidney disease who underwent...
solaci -
Learn More
Acute coronary syndromes

Errata sheet regarding the publication “The Impella device questioned in the post-approval studies due to an increase of adverse events”

What was published in our website refers to the original publication by the FDA (Increased rate of...
solaci -
Learn More
Coronary disease

The 10 Most Read Articles of January

1- These Were the Most Relevant Article of 2018 in the Field of Coronary Diseases Read the best...
solaci -
Learn More
Coronary disease

Mechanical Thrombectomy in Stroke Could Have Worse Results in Low Volume Centers

The number of centers that are starting endovascular stroke therapy (EST) to treat acute stroke is growing...
solaci -
Learn More
Chronic Ischemic cardiopathy

Clinical Events after Deferral of LAD Treatment Guided by FFR or iFR

iFR is a safe alternative for lesion deferral even when it comes to the left anterior descending...
solaci -
Learn More
Acute coronary syndromes

Optimal Revascularization Time in Transient STEMI

Patients admitted with transient ST elevation MI and later normalize completely (symptimos disappear before being treated) are...
solaci -
Learn More
Acute coronary syndromes

The Ten Commandments for the Fourth Universal Definition of Infarction

The Fourth Universal Definition of Myocardial Infarction is a document developed jointly by the European Society of...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy